{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:19:28Z","timestamp":1791332368092,"version":"4.3.1"},"publisher-location":"Cham","reference-count":121,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319131498","type":"print"},{"value":"9783319131504","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-13150-4_2","type":"book-chapter","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T02:05:53Z","timestamp":1423188353000},"page":"27-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pathology of B-Cell Lymphomas: Diagnosis and Biomarker Discovery"],"prefix":"10.1007","author":[{"given":"Sarah L.","family":"Ondrejka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,7]]},"reference":[{"issue":"12","key":"2_CR1","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/modpathol.2012.117","volume":"25","author":"P Adam","year":"2012","unstructured":"Adam P, Schiefer AI, Prill S, Henopp T, Quintanilla-Martinez L, Bosmuller HC, Chott A, Fend F (2012) Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues. Mod Pathol 25(12):1629\u20131636","journal-title":"Mod Pathol"},{"issue":"1","key":"2_CR2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1200\/JCO.2012.42.7906","volume":"31","author":"RH Advani","year":"2013","unstructured":"Advani RH, Buggy JJ, Sharman JP, Smith SM, Boyd TE, Grant B, Kolibaba KS, Furman RR, Rodriguez S, Chang BY et al (2013) Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed\/refractory B-cell malignancies. J Clin Oncol 31(1):88\u201394","journal-title":"J Clin Oncol"},{"issue":"6769","key":"2_CR3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769):503\u2013511","journal-title":"Nature"},{"issue":"10","key":"2_CR4","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1182\/blood.V90.10.4212","volume":"90","author":"NS Andersen","year":"1997","unstructured":"Andersen NS, Donovan JW, Borus JS, Poor CM, Neuberg D, Aster JC, Nadler LM, Freedman AS, Gribben JG (1997) Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease. Blood 90(10):4212\u20134221","journal-title":"Blood"},{"issue":"20","key":"2_CR5","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","volume":"28","author":"S Barrans","year":"2010","unstructured":"Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R, Roman E, Jack A (2010) Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol 28(20):3360\u20133365","journal-title":"J Clin Oncol"},{"issue":"45","key":"2_CR6","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","volume":"110","author":"S Bea","year":"2013","unstructured":"Bea S, Valdes-Mas R, Navarro A, Salaverria I, Martin-Garcia D, Jares P, Gine E, Pinyol M, Royo C, Nadeu F et al (2013) Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci USA 110(45):18250\u201318255","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2_CR7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3324\/haematol.2009.008862","volume":"94","author":"HW Bernd","year":"2009","unstructured":"Bernd HW, Ziepert M, Thorns C, Klapper W, Wacker HH, Hummel M, Stein H, Hansmann ML, Ott G, Rosenwald A et al (2009) Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma\u2014analyses of cases from two prospective randomized clinical trials. Haematologica 94(11):1569\u20131580","journal-title":"Haematologica"},{"issue":"4","key":"2_CR8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3324\/haematol.11267","volume":"93","author":"S Bottcher","year":"2008","unstructured":"Bottcher S, Ritgen M, Buske S, Gesk S, Klapper W, Hoster E, Hiddemann W, Unterhalt M, Dreyling M, Siebert R et al (2008) Minimal residual disease detection in mantle cell lymphoma: Methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations. Haematologica 93(4):551\u2013559","journal-title":"Haematologica"},{"issue":"5","key":"2_CR9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/modpathol.2011.213","volume":"25","author":"E Braggio","year":"2012","unstructured":"Braggio E, Dogan A, Keats JJ, Chng WJ, Huang G, Matthews JM, Maurer MJ, Law ME, Bosler DS, Barrett M et al (2012) Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Mod Pathol 25(5):651\u2013660","journal-title":"Mod Pathol"},{"issue":"8","key":"2_CR10","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.leu.2401831","volume":"14","author":"M Bruggemann","year":"2000","unstructured":"Bruggemann M, Droese J, Bolz I, Luth P, Pott C, von Neuhoff N, Scheuering U, Kneba M (2000) Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR. Leukemia 14(8):1419\u20131425","journal-title":"Leukemia"},{"key":"2_CR11","doi-asserted-by":"crossref","unstructured":"Cao Y, Hunter ZR, Liu X, Xu L, Yang G, Chen J, Patterson CJ, Tsakmaklis N, Kanan S, Rodig S, et al (2014) The WHIM-like CXCR4 somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of waldenstrom\u2019s macroglobulinemia. Leukemia\u00a0Jun 10. [Epub ahead of print]","DOI":"10.1038\/leu.2014.187"},{"issue":"2","key":"2_CR12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3324\/haematol.2011.052621","volume":"97","author":"A Carvajal-Cuenca","year":"2012","unstructured":"Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY, Sargent RL, Espinet B, Climent F, Jacobs SA et al (2012) In situ mantle cell lymphoma: Clinical implications of an incidental finding with indolent clinical behavior. Haematologica 97(2):270\u2013278","journal-title":"Haematologica"},{"issue":"17","key":"2_CR13","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","volume":"15","author":"WW Choi","year":"2009","unstructured":"Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, Braziel RM, Geng H, Iqbal J, Lenz G et al (2009) A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 15(17):5494\u20135502","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2_CR14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/bjh.12983","volume":"167","author":"AM Collie","year":"2014","unstructured":"Collie AM, Nolling J, Divakar KM, Lin JJ, Carver P, Durkin LM, Hill BT, Smith MR, Radivoyevitch T, Kong LI et al (2014) Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex system. Br J Haematol 167(2):281\u2013285","journal-title":"Br J Haematol"},{"issue":"4","key":"2_CR15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/PAS.0000000000000147","volume":"38","author":"JR Cook","year":"2014","unstructured":"Cook JR, Goldman B, Tubbs RR, Rimsza L, Leblanc M, Stiff P, Fisher R (2014) Clinical significance of MYC expression and\/or \u201chigh-grade\u201d morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: A SWOG S9704 correlative study. Am J Surg Pathol 38(4):494\u2013501","journal-title":"Am J Surg Pathol"},{"issue":"21","key":"2_CR16","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM et al (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351(21):2159\u20132169","journal-title":"N Engl J Med"},{"issue":"23","key":"2_CR17","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G et al (2006) Molecular diagnosis of Burkitt\u2019s lymphoma. N Engl J Med 354(23):2431\u20132442","journal-title":"N Engl J Med"},{"issue":"2","key":"2_CR18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2006.06439.x","volume":"136","author":"AJ Davies","year":"2007","unstructured":"Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, Chan WC, Delabie J, Braziel RM, Campo E et al (2007) Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol 136(2):286\u2013293","journal-title":"Br J Haematol"},{"issue":"8","key":"2_CR19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3109\/10428194.2011.573032","volume":"52","author":"CA De Mello","year":"2011","unstructured":"De Mello CA, De Andrade VP, De Lima VC, Carvalho AL, Soares FA (2011) Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma. Leuk Lymphoma 52(8):1495\u20131503","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2_CR20","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2007-10-117010","volume":"111","author":"O Determann","year":"2008","unstructured":"Determann O, Hoster E, Ott G, Wolfram Bernd H, Loddenkemper C, Leo Hansmann M, Barth TE, Unterhalt M, Hiddemann W, Dreyling M et al (2008) Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL network and the German low grade lymphoma study group. Blood 111(4):2385\u20132387","journal-title":"Blood"},{"issue":"11","key":"2_CR21","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3324\/haematol.2009.008474","volume":"94","author":"M Dictor","year":"2009","unstructured":"Dictor M, Ek S, Sundberg M, Warenholt J, Gyorgy C, Sernbo S, Gustavsson E, Abu-Alsoud W, Wadstrom T, Borrebaeck C (2009) Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt\u2019s lymphoma. Haematologica 94(11):1563\u20131568","journal-title":"Haematologica"},{"issue":"26","key":"2_CR22","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H Dohner","year":"2000","unstructured":"Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343(26):1910\u20131916","journal-title":"N Engl J Med"},{"issue":"4","key":"2_CR23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3324\/haematol.2010.033167","volume":"96","author":"FC Eberle","year":"2011","unstructured":"Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, Adams LG, Hewitt SM, Wilson WH, Pittaluga S et al (2011) Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin\u2019s lymphoma and primary mediastinal large B-cell lymphoma. Haematologica 96(4):558\u2013566","journal-title":"Haematologica"},{"issue":"4","key":"2_CR24","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/1078-0432.CCR-13-1077","volume":"20","author":"B Espinet","year":"2014","unstructured":"Espinet B, Ferrer A, Bellosillo B, Nonell L, Salar A, Fernandez-Rodriguez C, Puigdecanet E, Gimeno J, Garcia-Garcia M, Vela MC et al (2014) Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: From molecular profiling to flow cytometry. Clin Cancer Res 20(4):1007\u20131019","journal-title":"Clin Cancer Res"},{"issue":"27","key":"2_CR25","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, Pro B, Pileri S, Pulsoni A, Soubeyran P et al (2009) Follicular lymphoma international prognostic index 2: A new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 27(27):4555\u20134562","journal-title":"J Clin Oncol"},{"issue":"4","key":"2_CR26","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","volume":"70","author":"V Fernandez","year":"2010","unstructured":"Fernandez V, Salamero O, Espinet B, Sole F, Royo C, Navarro A, Camacho F, Bea S, Hartmann E, Amador V et al (2010) Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 70(4):1408\u20131418","journal-title":"Cancer Res"},{"issue":"7","key":"2_CR27","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/sj.leu.2404696","volume":"21","author":"J Fitzgibbon","year":"2007","unstructured":"Fitzgibbon J, Iqbal S, Davies A, O\u2019shea D, Carlotti E, Chaplin T, Matthews J, Raghavan M, Norton A, Lister TA et al (2007) Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma. Leukemia 21(7):1514\u20131520","journal-title":"Leukemia"},{"issue":"13","key":"2_CR28","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","volume":"106","author":"K Fu","year":"2005","unstructured":"Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R et al (2005) Cyclin D1-negative mantle cell lymphoma: A clinicopathologic study based on gene expression profiling. Blood 106(13):4315\u20134321","journal-title":"Blood"},{"issue":"1","key":"2_CR29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","volume":"27","author":"N Gachard","year":"2013","unstructured":"Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, Devesa M, Delage-Corre M, Coste V, Laforet MP et al (2013) IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and waldenstrom macroglobulinemia\/lymphoplasmacytic lymphomas. Leukemia 27(1):183\u2013189","journal-title":"Leukemia"},{"key":"2_CR30","unstructured":"Gaulard P, Harris NL, Pileri SA, Kutok J, Stein H, Kovrigina AM, Jaffe ES, Moller P (2008) Primary mediastinal (thymic) large B cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al (eds) WHO classification of tumours of the haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, 250 p"},{"issue":"4","key":"2_CR31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","volume":"25","author":"AM Glas","year":"2007","unstructured":"Glas AM, Knoops L, Delahaye L, Kersten MJ, Kibbelaar RE, Wessels LA, van Laar R, van Krieken JH, Baars JW, Raemaekers J et al (2007) Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 25(4):390\u2013398","journal-title":"J Clin Oncol"},{"issue":"1","key":"2_CR32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ajcp\/96.1.81","volume":"96","author":"CL Gonzalez","year":"1991","unstructured":"Gonzalez CL, Medeiros LJ, Jaffe ES (1991) Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin\u2019s disease and B-cell non-Hodgkin\u2019s lymphoma. Am J Clin Pathol 96(1):81\u201389","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2_CR33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.critrevonc.2010.09.003","volume":"80","author":"A Goy","year":"2011","unstructured":"Goy A, Kahl B (2011) Mantle cell lymphoma: The promise of new treatment options. Crit Rev Oncol Hematol 80(1):69\u201386","journal-title":"Crit Rev Oncol Hematol"},{"issue":"28","key":"2_CR34","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2011.41.4342","volume":"30","author":"TM Green","year":"2012","unstructured":"Green TM, Young KH, Visco C, Xu-Monette ZY, Orazi A, Go RS, Nielsen O, Gadeberg OV, Mourits-Andersen T, Frederiksen M et al (2012) Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol 30(28):3460\u20133467","journal-title":"J Clin Oncol"},{"issue":"9","key":"2_CR35","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","volume":"121","author":"MR Green","year":"2013","unstructured":"Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL, Kela I, Hopmans ES, Myklebust JH, Ji H et al (2013) Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 121(9):1604\u20131611","journal-title":"Blood"},{"issue":"12","key":"2_CR36","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/blood.V81.12.3449.3449","volume":"81","author":"JG Gribben","year":"1993","unstructured":"Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Spector N (1993) Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 81(12):3449\u20133457","journal-title":"Blood"},{"issue":"6","key":"2_CR37","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/sj.leu.2403738","volume":"19","author":"Y Guo","year":"2005","unstructured":"Guo Y, Karube K, Kawano R, Yamaguchi T, Suzumiya J, Huang GS, Ohshima K (2005) Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia 19(6):1058\u20131063","journal-title":"Leukemia"},{"issue":"1","key":"2_CR38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275\u2013282","journal-title":"Blood"},{"issue":"8","key":"2_CR39","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.pas.0000168176.71405.e5","volume":"29","author":"E Haralambieva","year":"2005","unstructured":"Haralambieva E, Boerma EJ, van Imhoff GW, Rosati S, Schuuring E, Muller-Hermelink HK, Kluin PM, Ott G (2005) Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol 29(8):1086\u20131094","journal-title":"Am J Surg Pathol"},{"key":"2_CR40","unstructured":"Harris N, Swerdlow S, Jaffe E, Ott G (2008) Follicular lymphoma. In: Swerdlow S, Campo E, Harris N, et al (eds) WHO classification of tumours of the haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, 220 p"},{"issue":"9","key":"2_CR41","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","volume":"96","author":"H Horn","year":"2011","unstructured":"Horn H, Schmelter C, Leich E, Salaverria I, Katzenberger T, Ott MM, Kalla J, Romero M, Siebert R, Rosenwald A et al (2011) Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles. Haematologica 96(9):1327\u20131334","journal-title":"Haematologica"},{"issue":"2","key":"2_CR42","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"E Hoster","year":"2008","unstructured":"Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H et al (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111(2):558\u2013565","journal-title":"Blood"},{"key":"2_CR43","doi-asserted-by":"crossref","unstructured":"Hu S, Xu-Monette ZY, Tzankov A, Green T, Wu L, Balasubramanyam A, Liu WM, Visco C, Li Y, Miranda RN, et al (2013) MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from the international DLBCL rituximab-CHOP consortium program. Blood 121(20):4021\u20134031; quiz 4250","DOI":"10.1182\/blood-2012-10-460063"},{"issue":"23","key":"2_CR44","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC et al (2006) A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med 354(23):2419\u20132430","journal-title":"N Engl J Med"},{"issue":"10","key":"2_CR45","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","volume":"122","author":"P Jares","year":"2012","unstructured":"Jares P, Colomer D, Campo E (2012) Molecular pathogenesis of mantle cell lymphoma. J Clin Invest 122(10):3416\u20133423","journal-title":"J Clin Invest"},{"issue":"8","key":"2_CR46","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/leu.2013.62","volume":"27","author":"C Jimenez","year":"2013","unstructured":"Jimenez C, Sebastian E, Chillon MC, Giraldo P, Mariano Hernandez J, Escalante F, Gonzalez-Lopez TJ, Aguilera C, de Coca AG, Murillo I et al (2013) MYD88 L265P is a marker highly characteristic of, but not restricted to, waldenstrom\u2019s macroglobulinemia. Leukemia 27(8):1722\u20131728","journal-title":"Leukemia"},{"issue":"1","key":"2_CR47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1200\/JCO.1995.13.1.140","volume":"13","author":"PW Johnson","year":"1995","unstructured":"Johnson PW, Rohatiner AZ, Whelan JS, Price CG, Love S, Lim J, Matthews J, Norton AJ, Amess JA, Lister TA (1995) Patterns of survival in patients with recurrent follicular lymphoma: A 20-year study from a single center. J Clin Oncol 13(1):140\u2013147","journal-title":"J Clin Oncol"},{"issue":"28","key":"2_CR48","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","volume":"30","author":"NA Johnson","year":"2012","unstructured":"Johnson NA, Slack GW, Savage KJ, Connors JM, Ben-Neriah S, Rogic S, Scott DW, Tan KL, Steidl C, Sehn LH et al (2012) Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol 30(28):3452\u20133459","journal-title":"J Clin Oncol"},{"key":"2_CR49","unstructured":"Kluin P, Harris N, Stein H, Leoncini L, Raphael M, Campo E, Jaffe E (2008) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma. In: Swerdlow S, Campo E, Harris N, et al (eds) WHO classification of tumours of the haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, 265 p"},{"issue":"12","key":"2_CR50","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.humpath.2012.03.025","volume":"43","author":"K Koch","year":"2012","unstructured":"Koch K, Hoster E, Unterhalt M, Ott G, Rosenwald A, Hansmann ML, Engelhard M, Hiddemann W, Klapper W (2012) The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease. Hum Pathol 43(12):2274\u20132281","journal-title":"Hum Pathol"},{"issue":"4","key":"2_CR51","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood.V84.4.1226.1226","volume":"84","author":"H Komatsu","year":"1994","unstructured":"Komatsu H, Iida S, Yamamoto K, Mikuni C, Nitta M, Takahashi T, Ueda R, Seto M (1994) A variant chromosome translocation at 11q13 identifying PRAD1\/cyclin D1 as the BCL-1 gene. Blood 84(4):1226\u20131231","journal-title":"Blood"},{"key":"2_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.44","author":"PY Kuo","year":"2014","unstructured":"Kuo PY, Leshchenko VV, Fazzari MJ, Perumal D, Gellen T, He T, Iqbal J, Baumgartner-Wennerholm S, Nygren L, Zhang F et al (2014) High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma. Oncogene. doi:10.1038\/onc.2014.44","journal-title":"Oncogene"},{"issue":"6","key":"2_CR53","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/leu.2013.375","volume":"28","author":"M Ladetto","year":"2014","unstructured":"Ladetto M, Bruggemann M, Monitillo L, Ferrero S, Pepin F, Drandi D, Barbero D, Palumbo A, Passera R, Boccadoro M et al (2014) Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. Leukemia 28(6):1299\u20131307","journal-title":"Leukemia"},{"key":"2_CR54","doi-asserted-by":"crossref","unstructured":"Landgren O, Staudt L (2012) MYD88 L265P somatic mutation in IgM MGUS. N Engl J Med 367(23):2255\u20132256; author reply 2256\u20137","DOI":"10.1056\/NEJMc1211959"},{"issue":"15","key":"2_CR55","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","volume":"362","author":"G Lenz","year":"2010","unstructured":"Lenz G, Staudt LM (2010) Aggressive lymphomas. N Engl J Med 362(15):1417\u20131429","journal-title":"N Engl J Med"},{"key":"2_CR56","unstructured":"Leoncini L, Raphael M, Stein H, Harris N, Jaffe E, Kluin P (2008) Burkitt lymphoma. In: Swerdlow S, Campo E, Harris N, et al (eds) WHO classification of tumors of the hematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, 262 p"},{"issue":"1","key":"2_CR57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","volume":"25","author":"S Li","year":"2012","unstructured":"Li S, Lin P, Fayad LE, Lennon P, Miranda RN, Yin CC, Lin E, Medeiros LJ (2012) B-cell lymphomas with MYC\/8q24 rearrangements and IGH@BCL2\/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Mod Pathol 25(1):145\u2013156","journal-title":"Mod Pathol"},{"issue":"8","key":"2_CR58","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2008.19.6121","volume":"27","author":"P Martin","year":"2009","unstructured":"Martin P, Chadburn A, Christos P, Weil K, Furman RR, Ruan J, Elstrom R, Niesvizky R, Ely S, Diliberto M et al (2009) Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol 27(8):1209\u20131213","journal-title":"J Clin Oncol"},{"issue":"2","key":"2_CR59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","volume":"29","author":"PN Meyer","year":"2011","unstructured":"Meyer PN, Fu K, Greiner TC, Smith LM, Delabie J, Gascoyne RD, Ott G, Rosenwald A, Braziel RM, Campo E et al (2011) Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol 29(2):200\u2013207","journal-title":"J Clin Oncol"},{"issue":"6","key":"2_CR60","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00401-011-0891-2","volume":"122","author":"M Montesinos-Rongen","year":"2011","unstructured":"Montesinos-Rongen M, Godlewska E, Brunn A, Wiestler OD, Siebert R, Deckert M (2011) Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma. Acta Neuropathol 122(6):791\u2013792","journal-title":"Acta Neuropathol"},{"issue":"7360","key":"2_CR61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M et al (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476(7360):298\u2013303","journal-title":"Nature"},{"issue":"11","key":"2_CR62","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","volume":"94","author":"A Mozos","year":"2009","unstructured":"Mozos A, Royo C, Hartmann E, De Jong D, Baro C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS et al (2009) SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 94(11):1555\u20131562","journal-title":"Haematologica"},{"issue":"20","key":"2_CR63","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","volume":"72","author":"A Navarro","year":"2012","unstructured":"Navarro A, Clot G, Royo C, Jares P, Hadzidimitriou A, Agathangelidis A, Bikos V, Darzentas N, Papadaki T, Salaverria I et al (2012) Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res 72(20):5307\u20135316","journal-title":"Cancer Res"},{"issue":"7332","key":"2_CR64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","volume":"470","author":"VN Ngo","year":"2011","unstructured":"Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H et al (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature 470(7332):115\u2013119","journal-title":"Nature"},{"issue":"2","key":"2_CR65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12185-010-0666-x","volume":"92","author":"N Niitsu","year":"2010","unstructured":"Niitsu N (2010) Current treatment strategy of diffuse large B-cell lymphomas. Int J Hematol 92(2):231\u2013237","journal-title":"Int J Hematol"},{"issue":"1","key":"2_CR66","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/bjh.12854","volume":"166","author":"L Nordstrom","year":"2014","unstructured":"Nordstrom L, Sernbo S, Eden P, Gronbaek K, Kolstad A, Raty R, Karjalainen ML, Geisler C, Ralfkiaer E, Sundstrom C et al (2014) SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma\u2014a nordic lymphoma group study. Br J Haematol 166(1):98\u2013108","journal-title":"Br J Haematol"},{"issue":"18","key":"2_CR67","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2011-12-400580","volume":"119","author":"L Nygren","year":"2012","unstructured":"Nygren L, Baumgartner Wennerholm S, Klimkowska M, Christensson B, Kimby E, Sander B (2012) Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood 119(18):4215\u20134223","journal-title":"Blood"},{"issue":"8","key":"2_CR68","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","volume":"96","author":"SL Ondrejka","year":"2011","unstructured":"Ondrejka SL, Lai R, Smith SD, Hsi ED (2011) Indolent mantle cell leukemia: A clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica 96(8):1121\u20131127","journal-title":"Haematologica"},{"issue":"3","key":"2_CR69","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1309\/AJCP10ZCLFZGYZIP","volume":"140","author":"SL Ondrejka","year":"2013","unstructured":"Ondrejka SL, Lin JJ, Warden DW, Durkin L, Cook JR, Hsi ED (2013) MYD88 L265P somatic mutation: Its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders. Am J Clin Pathol 140(3):387\u2013394","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"2_CR70","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","volume":"101","author":"J Orchard","year":"2003","unstructured":"Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E, Catovsky D, Thomas PW, Avet-Loiseau H, Oscier D (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101(12):4975\u20134981","journal-title":"Blood"},{"issue":"2","key":"2_CR71","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2010.030809","volume":"96","author":"I Oschlies","year":"2011","unstructured":"Oschlies I, Burkhardt B, Salaverria I, Rosenwald A, d\u2019Amore ES, Szczepanowski M, Koch K, Hansmann ML, Stein H, Moller P et al (2011) Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children. Haematologica 96(2):262\u2013268","journal-title":"Haematologica"},{"issue":"4","key":"2_CR72","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood.V89.4.1421","volume":"89","author":"G Ott","year":"1997","unstructured":"Ott G, Kalla J, Ott MM, Schryen B, Katzenberger T, Muller JG, Muller-Hermelink HK (1997) Blastoid variants of mantle cell lymphoma: Frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood 89(4):1421\u20131429","journal-title":"Blood"},{"issue":"2","key":"2_CR73","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","volume":"30","author":"RG Owen","year":"2003","unstructured":"Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, Morra E, Pangalis GA, San Miguel JF, Branagan AR et al (2003) Clinicopathological definition of waldenstrom\u2019s macroglobulinemia: Consensus panel recommendations from the second international workshop on waldenstrom\u2019s macroglobulinemia. Semin Oncol 30(2):110\u2013115","journal-title":"Semin Oncol"},{"issue":"7337","key":"2_CR74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J et al (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471(7337):189\u2013195","journal-title":"Nature"},{"issue":"3","key":"2_CR75","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bjh.12763","volume":"165","author":"AM Perry","year":"2014","unstructured":"Perry AM, Alvarado-Bernal Y, Laurini JA, Smith LM, Slack GW, Tan KL, Sehn LH, Fu K, Aoun P, Greiner TC et al (2014) MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab. Br J Haematol 165(3):382\u2013391","journal-title":"Br J Haematol"},{"issue":"8","key":"2_CR76","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/jid.2012.102","volume":"132","author":"A Pham-Ledard","year":"2012","unstructured":"Pham-Ledard A, Cappellen D, Martinez F, Vergier B, Beylot-Barry M, Merlio JP (2012) MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type. J Invest Dermatol 132(8):2118\u20132120","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2_CR77","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/j.seminhematol.2011.05.002","volume":"48","author":"C Pott","year":"2011","unstructured":"Pott C (2011) Minimal residual disease detection in mantle cell lymphoma: Technical aspects and clinical relevance. Semin Hematol 48(3):172\u2013184","journal-title":"Semin Hematol"},{"key":"2_CR78","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-62703-269-8_10","volume":"971","author":"C Pott","year":"2013","unstructured":"Pott C, Bruggemann M, Ritgen M, van der Velden VH, van Dongen JJ, Kneba M (2013) MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR. Methods Mol Biol 971:175\u2013200","journal-title":"Methods Mol Biol"},{"issue":"4","key":"2_CR79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12308-009-0053-9","volume":"2","author":"L Quintanilla-Martinez","year":"2009","unstructured":"Quintanilla-Martinez L, de Jong D, de Mascarel A, Hsi ED, Kluin P, Natkunam Y, Parrens M, Pileri S, Ott G (2009) Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European association for hematopathology and the society of hematopathology in Bordeaux, France. J Hematop 2(4):211\u2013236","journal-title":"J Hematop"},{"issue":"12","key":"2_CR80","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","volume":"44","author":"J Richter","year":"2012","unstructured":"Richter J, Schlesner M, Hoffmann S, Kreuz M, Leich E, Burkhardt B, Rosolowski M, Ammerpohl O, Wagener R, Bernhart SH et al (2012) Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet 44(12):1316\u20131320","journal-title":"Nat Genet"},{"issue":"11","key":"2_CR81","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/1078-0432.CCR-10-2573","volume":"17","author":"LM Rimsza","year":"2011","unstructured":"Rimsza LM, Wright G, Schwartz M, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Cook JR et al (2011) Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues. Clin Cancer Res 17(11):3727\u20133732","journal-title":"Clin Cancer Res"},{"issue":"25","key":"2_CR82","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM et al (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346(25):1937\u20131947","journal-title":"N Engl J Med"},{"issue":"6","key":"2_CR83","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","volume":"198","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC et al (2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198(6):851\u2013862","journal-title":"J Exp Med"},{"issue":"8","key":"2_CR84","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/leu.2012.72","volume":"26","author":"C Royo","year":"2012","unstructured":"Royo C, Navarro A, Clot G, Salaverria I, Gine E, Jares P, Colomer D, Wiestner A, Wilson WH, Vegliante MC et al (2012) Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia 26(8):1895\u20131898","journal-title":"Leukemia"},{"issue":"12","key":"2_CR85","doi-asserted-by":"crossref","first-page":"e28585","DOI":"10.1371\/journal.pone.0028585","volume":"6","author":"RJ Ryan","year":"2011","unstructured":"Ryan RJ, Nitta M, Borger D, Zukerberg LR, Ferry JA, Harris NL, Iafrate AJ, Bernstein BE, Sohani AR, Le LP (2011) EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas. PLoS ONE 6(12):e28585","journal-title":"PLoS ONE"},{"issue":"1","key":"2_CR86","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/modpathol.2012.178","volume":"26","author":"JW Said","year":"2013","unstructured":"Said JW (2013) Aggressive B-cell lymphomas: How many categories do we need? Mod Pathol 26(1):S42\u2013S56","journal-title":"Mod Pathol"},{"issue":"9","key":"2_CR87","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.13071","volume":"93","author":"I Salaverria","year":"2008","unstructured":"Salaverria I, Zettl A, Bea S, Hartmann EM, Dave SS, Wright GW, Boerma EJ, Kluin PM, Ott G, Chan WC et al (2008) Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt\u2019s lymphoma. Haematologica 93(9):1327\u20131334","journal-title":"Haematologica"},{"issue":"8","key":"2_CR88","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","volume":"121","author":"I Salaverria","year":"2013","unstructured":"Salaverria I, Royo C, Carvajal-Cuenca A, Clot G, Navarro A, Valera A, Song JY, Woroniecka R, Rymkiewicz G, Klapper W et al (2013) CCND2 rearrangements are the most frequent genetic events in cyclin D1(\u2212) mantle cell lymphoma. Blood 121(8):1394\u20131402","journal-title":"Blood"},{"issue":"17","key":"2_CR89","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","volume":"114","author":"KJ Savage","year":"2009","unstructured":"Savage KJ, Johnson NA, Ben-Neriah S, Connors JM, Sehn LH, Farinha P, Horsman DE, Gascoyne RD (2009) MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 114(17):3533\u20133537","journal-title":"Blood"},{"issue":"7418","key":"2_CR90","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E et al (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490(7418):116\u2013120","journal-title":"Nature"},{"issue":"8","key":"2_CR91","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","volume":"123","author":"DW Scott","year":"2014","unstructured":"Scott DW, Wright GW, Williams PM, Lih CJ, Walsh W, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM et al (2014) Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood 123(8):1214\u20131217","journal-title":"Blood"},{"issue":"5","key":"2_CR92","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","volume":"109","author":"LH Sehn","year":"2007","unstructured":"Sehn LH, Berry B, Chhanabhai M, Fitzgerald C, Gill K, Hoskins P, Klasa R, Savage KJ, Shenkier T, Sutherland J et al (2007) The revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 109(5):1857\u20131861","journal-title":"Blood"},{"issue":"7","key":"2_CR93","first-page":"1401","volume":"7","author":"M Seto","year":"1992","unstructured":"Seto M, Yamamoto K, Iida S, Akao Y, Utsumi KR, Kubonishi I, Miyoshi I, Ohtsuki T, Yawata Y, Namba M (1992) Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 7(7):1401\u20131406","journal-title":"Oncogene"},{"issue":"14","key":"2_CR94","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"MA Shipp","year":"1993","unstructured":"Shipp MA (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The international non-Hodgkin\u2019s lymphoma prognostic factors project. N Engl J Med 329(14):987\u2013994","journal-title":"N Engl J Med"},{"issue":"8","key":"2_CR95","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.leukres.2014.04.007","volume":"38","author":"AT Simonsen","year":"2014","unstructured":"Simonsen AT, Sorensen CD, Ebbesen LH, Bodker JS, Bentzen HH, Nyvold CG (2014) SOX11 as a minimal residual disease marker for mantle cell lymphoma. Leuk Res 38(8):918\u2013924","journal-title":"Leuk Res"},{"issue":"5","key":"2_CR96","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-Celigny","year":"2004","unstructured":"Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, Au WY, Bellei M, Brice P, Caballero D et al (2004) Follicular lymphoma international prognostic index. Blood 104(5):1258\u20131265","journal-title":"Blood"},{"issue":"1","key":"2_CR97","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/PAS.0b013e3182a43996","volume":"38","author":"D Soldini","year":"2014","unstructured":"Soldini D, Valera A, Sole C, Palomero J, Amador V, Martin-Subero JI, Ribera-Cortada I, Royo C, Salaverria I, Bea S et al (2014) Assessment of SOX11 expression in routine lymphoma tissue sections: Characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma. Am J Surg Pathol 38(1):86\u201393","journal-title":"Am J Surg Pathol"},{"issue":"7338","key":"2_CR98","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","volume":"471","author":"C Steidl","year":"2011","unstructured":"Steidl C, Shah SP, Woolcock BW, Rui L, Kawahara M, Farinha P, Johnson NA, Zhao Y, Telenius A, Neriah SB et al (2011) MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471(7338):377\u2013381","journal-title":"Nature"},{"issue":"6","key":"2_CR99","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdp460","volume":"21","author":"JW Sweetenham","year":"2010","unstructured":"Sweetenham JW, Goldman B, LeBlanc ML, Cook JR, Tubbs RR, Press OW, Maloney DG, Fisher RI, Rimsza LM, Braziel RM et al (2010) Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: A southwest oncology group study. Ann Oncol 21(6):1196\u20131202","journal-title":"Ann Oncol"},{"key":"2_CR100","unstructured":"Swerdlow S, Campo E, Seto M, Muller-Hermelink HK (2008a) Mantle cell lymphoma. In: Swerdlow S, Campo E, Harris N, et al (eds) WHO classification of tumours of the hematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, 229 p"},{"key":"2_CR101","unstructured":"Swerdlow S, Berger F, Pileri S, Harris N, Jaffe E, Stein H (2008b) Lymphoplasmacytic lymphoma. In: Swerdlow S, Campo E, Harris N, et al (eds) Of tumours of haematopoietic and lymphoid tissues, fourth edition, 4th edn. 194 p"},{"issue":"9","key":"2_CR102","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1158\/1078-0432.CCR-09-3269","volume":"16","author":"M Taskinen","year":"2010","unstructured":"Taskinen M, Valo E, Karjalainen-Lindsberg ML, Hautaniemi S, Meri S, Leppa S (2010) Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP. Clin Cancer Res 16(9):2615\u20132623","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2_CR103","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","volume":"131","author":"M Tiemann","year":"2005","unstructured":"Tiemann M, Schrader C, Klapper W, Dreyling MH, Campo E, Norton A, Berger F, Kluin P, Ott G, Pileri S et al (2005) Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL network. Br J Haematol 131(1):29\u201338","journal-title":"Br J Haematol"},{"issue":"11","key":"2_CR104","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","volume":"29","author":"A Traverse-Glehen","year":"2005","unstructured":"Traverse-Glehen A, Pittaluga S, Gaulard P, Sorbara L, Alonso MA, Raffeld M, Jaffe ES (2005) Mediastinal gray zone lymphoma: The missing link between classic Hodgkin\u2019s lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol 29(11):1411\u20131421","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"2_CR105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C et al (2012) MYD88 L265P somatic mutation in waldenstrom\u2019s macroglobulinemia. N Engl J Med 367(9):826\u2013833","journal-title":"N Engl J Med"},{"issue":"7","key":"2_CR106","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/modpathol.2013.214","volume":"27","author":"A Tzankov","year":"2013","unstructured":"Tzankov A, Xu-Monette ZY, Gerhard M, Visco C, Dirnhofer S, Gisin N, Dybkaer K, Orazi A, Bhagat G, Richards KL et al (2013) Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol 27(7):958\u2013971","journal-title":"Mod Pathol"},{"issue":"1","key":"2_CR107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<85::AID-GCC11>3.0.CO;2-9","volume":"27","author":"JW Vaandrager","year":"2000","unstructured":"Vaandrager JW, Schuuring E, Raap T, Philippo K, Kleiverda K, Kluin P (2000) Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes. Genes Chromosomes Cancer 27(1):85\u201394","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"2_CR108","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","volume":"21","author":"VH van der Velden","year":"2007","unstructured":"van der Velden VH, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer ER, Flohr T, Sutton R, Cave H, Madsen HO et al (2007) Analysis of minimal residual disease by Ig\/TCR gene rearrangements: Guidelines for interpretation of real-time quantitative PCR data. Leukemia 21(4):604\u2013611","journal-title":"Leukemia"},{"issue":"13","key":"2_CR109","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1182\/blood-2013-07-513366","volume":"122","author":"M Varettoni","year":"2013","unstructured":"Varettoni M, Zibellini S, Arcaini L, Boveri E, Rattotti S, Pascutto C, Mangiacavalli S, Gotti M, Pochintesta L, Paulli M et al (2013) MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance. Blood 122(13):2284\u20132285","journal-title":"Blood"},{"issue":"2","key":"2_CR110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3324\/haematol.2012.066209","volume":"98","author":"C Visco","year":"2013","unstructured":"Visco C, Tzankov A, Xu-Monette ZY, Miranda RN, Tai YC, Li Y, Liu WM, d\u2019Amore ES, Li Y, Montes-Moreno S et al (2013) Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: A report from an international DLBCL rituximab-CHOP consortium program study. Haematologica 98(2):255\u2013263","journal-title":"Haematologica"},{"issue":"2","key":"2_CR111","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1158\/1078-0432.CCR-09-2487","volume":"16","author":"BE Wahlin","year":"2010","unstructured":"Wahlin BE, Aggarwal M, Montes-Moreno S, Gonzalez LF, Roncador G, Sanchez-Verde L, Christensson B, Sander B, Kimby E (2010) A unifying microenvironment model in follicular lymphoma: Outcome is predicted by programmed death-1\u2013positive, regulatory, cytotoxic, and helper T cells and macrophages. Clin Cancer Res 16(2):637\u2013650","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2_CR112","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2141.2011.08942.x","volume":"156","author":"BE Wahlin","year":"2012","unstructured":"Wahlin BE, Yri OE, Kimby E, Holte H, Delabie J, Smeland EB, Sundstrom C, Christensson B, Sander B (2012) Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times. Br J Haematol 156(2):225\u2013233","journal-title":"Br J Haematol"},{"issue":"7","key":"2_CR113","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/1097-0142(19820401)49:7<1429::AID-CNCR2820490720>3.0.CO;2-5","volume":"49","author":"DD Weisenburger","year":"1982","unstructured":"Weisenburger DD, Kim H, Rappaport H (1982) Mantle-zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma. Cancer 49(7):1429\u20131438","journal-title":"Cancer"},{"key":"2_CR114","doi-asserted-by":"crossref","unstructured":"Wilson W, et al (2012) The bruton\u2019s tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), has preferential activity in the ABC subtype of relapsed\/refractory de novo diffuse large B-cell lymphoma: Interim results of a multicenter, open-label, phase 2 study. Proc Ash (Abstract 686)","DOI":"10.1182\/blood.V120.21.686.686"},{"issue":"17","key":"2_CR115","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","volume":"100","author":"G Wright","year":"2003","unstructured":"Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM (2003) A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 100(17):9991\u20139996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR116","doi-asserted-by":"crossref","unstructured":"Xu L, Hunter ZR, Yang G, Cao Y, Liu X, Manning R, Tripsas C, Chen J, Patterson CJ, Kluk M, et al (2014) Detection of MYD88 L265P in peripheral blood of patients with waldenstrom\u2019s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. Leukemia\u00a028(8):1698\u2013704.","DOI":"10.1038\/leu.2014.65"},{"issue":"7","key":"2_CR117","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood-2012-12-475111","volume":"122","author":"G Yang","year":"2013","unstructured":"Yang G, Zhou Y, Liu X, Xu L, Cao Y, Manning RJ, Patterson CJ, Buhrlage SJ, Gray N, Tai YT et al (2013) A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of bruton tyrosine kinase in waldenstrom macroglobulinemia. Blood 122(7):1222\u20131232","journal-title":"Blood"},{"issue":"9","key":"2_CR118","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/PAS.0b013e3181e9343d","volume":"34","author":"SF Younes","year":"2010","unstructured":"Younes SF, Beck AH, Lossos IS, Levy R, Warnke RA, Natkunam Y (2010) Immunoarchitectural patterns in follicular lymphoma: Efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components. Am J Surg Pathol 34(9):1266\u20131276","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"2_CR119","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00000478-199209000-00007","volume":"16","author":"A Zarate-Osorno","year":"1992","unstructured":"Zarate-Osorno A, Medeiros LJ, Longo DL, Jaffe ES (1992) Non-Hodgkin\u2019s lymphomas arising in patients successfully treated for Hodgkin\u2019s disease. A clinical, histologic, and immunophenotypic study of 14 cases. Am J Surg Pathol 16(9):885\u2013895","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2_CR120","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PAS.0b013e318241f050","volume":"36","author":"W Zeng","year":"2012","unstructured":"Zeng W, Fu K, Quintanilla-Fend L, Lim M, Ondrejka S, Hsi ED (2012) Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Am J Surg Pathol 36(2):214\u2013219","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2_CR121","doi-asserted-by":"crossref","first-page":"e95020","DOI":"10.1371\/journal.pone.0095020","volume":"9","author":"K Zhou","year":"2014","unstructured":"Zhou K, Xu D, Cao Y, Wang J, Yang Y, Huang M (2014) C-MYC aberrations as prognostic factors in diffuse large B-cell lymphoma: A meta-analysis of epidemiological studies. PLoS ONE 9(4):e95020","journal-title":"PLoS ONE"}],"container-title":["Cancer Treatment and Research","Non-Hodgkin Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-13150-4_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T10:38:57Z","timestamp":1674556737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-13150-4_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319131498","9783319131504"],"references-count":121,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-13150-4_2","relation":{},"ISSN":["0927-3042"],"issn-type":[{"value":"0927-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"7 February 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}